PTCE Pharmacy Connect | Pharmacy Times

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Educational Objectives

Faculty:

Joseph Saseen, PharmD, BCPS, BCACP, CLS

Professor and Associate Dean for Clinical Affairs

University of Colorado Anschutz Medical Campus

Skaggs School of Pharmacy and Pharmaceutical Sciences

Aurora, Colorado

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Executive Director, Ambulatory Pharmacy Services

Grady Health System

Atlanta, Georgia

Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))

Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose:

Grant/Research Support: Novartis

Consultant: Novartis, Regeneron

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.

This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Please follow the link below to access this activity on PTCE and claim CE credit:

www.pharmacytimes.org/hyperlipidemiapodcast

Educational Objectives

• Review recent clinical updates of RET inhibitors and how they fit into the treatment paradigm for non‒small cell lung cancer

Faculty

Lauren Ledbetter, PharmD, BCOP

Clinical Pharmacy Specialist, Thoracic Medical Oncology

The James Cancer Hospital at The Ohio State University

Columbus, Ohio

Moderator

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager

University of Kansas Cancer Center

Division of Hematologic Malignancies & Cellular Therapeutics

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-24-304-H01-P. The activity is available for CE credit through October 31, 2025.

This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.

Educational Objectives

• Review challenges that impact optimal treatment of skin barrier dysfunction in patients with acne who are seeking OTC care

• List strategies to individualize patient care and improve recommendations for patients with acne experiencing skin barrier dysfunction

Faculty:

Robin Laird

Patient Advocate

Los Angeles, California

Mary Barna Bridgeman, PharmD, BCPS, BCGP

Clinical Professor

Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey

Piscataway, New Jersey

Internal Medicine Pharmacist

Robert Wood Johnson University Hospital-New Brunswick

New Brunswick, New Jersey

Mary Barna Bridgeman, PharmD, BCPS, BCGP, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Liza Patel, PharmD, RPh; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.05 CEU) under the ACPE universal activity numbers 0290-0000-24-128-H01-P and 0290-0000-24-128-H01-T. The activity is available for CE credit through April 29, 2025.

This activity is supported by an educational grant from CeraVe. 

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Title: Challenges in Treatment of Desmoid Tumors and Managed Care Solutions

Educational Objectives

Moderator:

Laura Bobolts, PharmD, BCOP

Senior Vice President of Clinical Strategy and Growth

OncoHealth

Plantation, Florida

Faculty:

Christy Harris, PharmD, BCOP, FHOPA    

Clinical Pharmacy Specialist                                                               

Dana-Farber Cancer Institute

Associate Professor

Massachusetts College of Pharmacy and Health Sciences

Boston, Massachusetts

Christy Harris, PharmD, BCOP, FHOPA and Laura Bobolts, PharmD, BCOP have no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-421-H01-P. The activity is available for CE credit through February 28, 2024.

This activity is supported by an educational grant from SpringWorks Therapeutics.

To claim CE credit for this activity, please follow this link: www.pharmacytimes.org/atopic-derm-podcast-630

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Educational Objectives

• Review patient barriers that impact optimal treatment of patients with atopic dermatitis (AD) who are seeking OTC care

Moderator:

Mary Bridgeman, PharmD, BCPS, BCGP

Clinical Professor

Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey

Piscataway, New Jersey

Internal Medicine Clinical Pharmacist

Robert Wood Johnson University Hospital

New Brunswick, New Jersey

Faculty & Caregiver:

Ashley Ellis, PharmD, MBA, CDECS

ImPAcT Director & Assistant Professor

The University of Tennessee Health Science Center

Department of Clinical Pharmacy and Translation Science College of Pharmacy

Memphis, Tennessee

Mary Bridgeman, PharmD, BCPS, BCGP has no financial relationships with commercial interests to disclose.

Grant/Research Support: Researcher AHRQ “Tennessee Heart Health Network” funding in form of salary release dollars

Consultant: Global Parents for Eczema Research, Continuing Education Alliance, McGraw Hill

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-268-H01-P and 0290-0000-23-268-H01-T. The activity is available for CE credit through June 30, 2024.

This activity is supported by an educational grant from CeraVe and La Roche-Posay.

Brought to you in partnership with the National Eczema Association.

Educational Objectives

• Outline the place in therapy for targeted therapies based on patient-specific factors and subtype of early-stage breast cancer

Faculty:

Allison R. Butts, PharmD, BCOP

Pharmacist Manager, Oncology

Breast Oncology Clinical Pharmacy Specialist

Acute Care Pharmacy Services

UK HealthCare- Markey Cancer

Lexington, Kentucky

Director, PGY2 Oncology Residency Program

UK HealthCare

Lexington, Kentucky

Allison R. Butts, PharmD, BCOP, has the following financial relationships with commercial interests to disclose:

Consultant: AstraZeneca; BeyondSpring (one-time advisory boards)

Moderator:

Laura R. Bobolts, PharmD, BCOP

SVP, Clinical Strategy and Growth

OncoHealth

Laura R. Bobolts, PharmD, BCOP, has no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-239-H01-P. The activity is available for CE credit through May 31, 2024.

This activity is supported by independent medical educational grants from AstraZeneca; Merck & Co., Inc.; Puma Biotechnology Inc., and Lilly.

Educational Objectives

• Recall the pathophysiology and clinical manifestations of Duchenne muscular dystrophy (DMD), as well as the burden of DMD and its impact on patient quality of life

Faculty:

Amanda Hickman, PharmD, MPH, MSCS

Central Support Pharmacist – Neuro/Psych/Sleep

Trellis Rx

Atlanta, Georgia

Moderator:

Jessica L. Kerr, PharmD, CDCES

Associate Dean – Office Professional and Student Affairs

Professor/Clinical Pharmacist

Southern Illinois University Edwardsville

School of Pharmacy

Edwardsville, Illinois

Amanda Hickman, PharmD, MPH, MSCS, and Jessica L. Kerr, PharmD, CDCES, have no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-613-H01-P. The activity is available for CE credit through December 22, 2023.

This activity is supported by an educational grant from Sarepta Therapeutics.

Educational Objective:

• Outline various challenges and uncertainties affecting the optimization of treatment with novel immunotherapeutic modalities for relapsed/refractory diffuse large B-cell lymphoma.

Faculty:

Victoria Nachar, PharmD, BCOP

Clinical Pharmacist Specialist - Hematology

University of Michigan Rogel Cancer Center

Ann Arbor, Michigan

Moderator:

Laura R. Bobolts, PharmD, BCOP

SVP, Clinical Strategy and Growth

OncoHealth

Plantation, Florida

Victoria Nachar, PharmD, BCOP & Laura R. Bobolts, PharmD, BCOP, have no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-22-611-H01-P. The activity is available for CE credit through December 22, 2023.

This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc; Genmab; and AbbVie, Inc.

Educational Objectives

• Outline current guideline recommendations and strategies pharmacists can implement for the management of immune thrombocytopenia (ITP)

• Recall the efficacy and safety of emerging agents for the treatment of ITP

Moderator:

Anthony J. Perissinotti, PharmD, BCOP

To claim CE credit for this activity, please visit the link below:

https://www.pharmacytimes.org/courses/advances-in-the-treatment-of-immune-thrombocytopenia-strategies-for-optimizing-clinical-and-patient-outcomes

Hematology Clinical Pharmacist Specialist

Clinical Team Leader Hematology/Oncology

Adjunct Clinical Assistant Professor

University of Michigan – Michigan Medicine

Ann Arbor, Michigan

Faculty:

Lisa Charneski, PharmD, BCPS

Assistant Dean for Academic Affairs

Philadelphia College of Pharmacy

Associate Professor of Clinical Pharmacy

Department of Pharmacy Practice Saint Joseph’s University

Philadelphia, Pennsylvania

Anthony J. Perissinotti, PharmD, BCOP has the following relevant financial relationships with commercial interests to disclose:

Lisa Charneski, PharmD, BCPS, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.1 CEU) under the ACPE universal activity number 0290-0000-22-608-H01-P. The activity is available for CE credit through December 19, 2023.

This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.